Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANO1 | Q5XXA6 | 1/20 | 1.00 |
| ▸ | ANO2 | Q9NQ90 | 1/20 | 1.00 |
| ▸ | CTSV | O60911 | 3/20 | 0.63 |
| ▸ | CTSL | P07711 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | MYC | P01106 | 1/20 | 0.52 |
| ▸ | MAX | P61244 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16737209 | 1.00 | ANO1 (1.00) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737120 | 0.92 | ANO1 (0.84) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737098 | 0.88 | ANO1 (0.79) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737100 | 0.84 | ANO1 (0.72) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737170 | 0.84 | ANO1 (0.72) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737203 | 0.84 | ANO1 (0.72) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737099 | 0.83 | ANO1 (0.71) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737089 | 0.82 | ANO1 (0.70) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737168 | 0.82 | ANO1 (0.70) | ANO1ANO2CTSVCTSLMAPT | |
| SCHEMBL16737171 | 0.82 | CDC25B (0.69) | ANO1ANO2CTSVCTSLMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312336-A1 | Compositions And Methods For Treating Cancer With Calcium Channel Inhibitors | INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER (US) | 2025-10-09 | — | — | US | claimed |
| US-20240122922-A1 | Methods Of Treating Cancer With Transmembrane Protein 16F (TMEM16F) Inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-04-18 | — | — | US | claimed |
| US-20260109872-A1 | Ink Jet Ink Composition And Ink Jet Recording Method | SEIKO EPSON CORP (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20260071230-A1 | Precise Bioengineering Of Flowering Time For Bioenergy Production And Gene Containment | U.S. DEPARTMENT OF ENERGY | 2026-03-12 | — | — | US | disclosed |
| EP-4707350-A1 | TREATMENT LIQUID COMPOSITION FOR DYE PRINTING, INK SET, AND RECORDING METHOD | Seiko Epson Corporation (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-4484154-B1 | GARMENT FABRIC AND GARMENT FABRIC MANUFACTURING METHOD | SEIKO EPSON CORP (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20250389081-A1 | Treatment Liquid Composition For Dye Printing, Ink Set, And Recording Method | SEIKO EPSON CORP (JP) | 2025-12-25 | — | — | US | disclosed |
| US-12492403-B2 | Aptamers and the use thereof in the treatment of cancer | FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL RAMÓN Y CAJAL (ES) | 2025-12-09 | — | — | US | disclosed |
| US-12486415-B2 | Ink jet textile-printing ink composition, recording method, and recorded material | SEIKO EPSON CORPORATION (JP) | 2025-12-02 | — | — | US | disclosed |
| EP-4637541-A1 | DEVICE, SYSTEM AND METHOD FOR MONITORING A SITE OF INTEREST INTERNAL TO A PATIENT BODY | Exero Medical Ltd. (IL) | 2025-10-29 | — | — | EP | disclosed |
| US-20250312336-A1 | Compositions And Methods For Treating Cancer With Calcium Channel Inhibitors | INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER (US) | 2025-10-09 | — | — | US | disclosed |
| CN-114318909-A | Printing method, printed matter, and recording apparatus | 精工爱普生株式会社 | 2022-04-12 | — | — | CN | disclosed |
| EP-3978680-A1 | TEXTILE PRINTING METHOD, PRINTED MATTER, AND RECORDING APPARATUS | Seiko Epson Corporation (JP) | 2022-04-06 | — | — | EP | disclosed |
| US-20220097435-A1 | Textile Printing Method, Printed Matter, And Recording Apparatus | SEIKO EPSON CORPORATION (JP) | 2022-03-31 | — | — | US | disclosed |
| CN-109628469-B | Molecular marker for identifying barley half-dwarf multi-tillering gene Hvhtd based on intron 2 and application thereof | 浙江省农业科学院 | 2022-03-29 | — | — | CN | disclosed |
| CN-111279300-B | Providing a rich electronic reading experience in a multi-display environment | 华为技术有限公司 | 2022-03-29 | — | — | CN | disclosed |
| US-11274074-B2 | Pharmaceutical composition for ANO1 antagonist with anticancer activity | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2022-03-15 | — | — | US | disclosed |
| CN-109321037-B | Ink for ink jet textile printing and ink set for ink jet textile printing | 精工爱普生株式会社 | 2022-02-15 | — | — | CN | disclosed |
| US-20220042018-A1 | APTAMERS AND THE USE THEREOF IN THE TREATMENT OF CANCER | FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL RAMÓN Y CAJAL (ES) | 2022-02-10 | — | — | US | disclosed |
| CN-110136087-B | Self-adaptive frame adjusting method of display terminal and related equipment | 京东方艺云科技有限公司 | 2022-01-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11274074-B2 | Pharmaceutical composition for ANO1 antagonist with anticancer activity | ANO1, ANO2, TMEM109 | ANO1 1/4885ANO2 2/4885CTSV 3807/4885 |
| US-20250389081-A1 | Treatment Liquid Composition For Dye Printing, Ink Set, And Recording Method | SORD, ME1, G6PD | ANO1 299/4885ANO2 500/4885CTSV 4457/4885 |
| US-20260109872-A1 | Ink Jet Ink Composition And Ink Jet Recording Method | COPE, EED, VCL | ANO1 2973/4885ANO2 3623/4885CTSV 3767/4885 |
| US-20260071230-A1 | Precise Bioengineering Of Flowering Time For Bioenergy Production And Gene Containment | STARD10, ZMYND8, OSBPL8 | ANO1 3757/4885ANO2 3791/4885CTSV 3210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.